Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Hansford JR"'
Autor:
Renzi S, Michaeli O, Salvador-Hernandez H, Alderete D, Ponce NF, Zapotocky M, Hansford JR, Malalasekera VS, Toledano H, Maguire B, Bouffet E, Ramaswamy V, Baroni LV
Publikováno v:
PEDIATRIC BLOOD & CANCER
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Seventeen children at six institutions with neurofibromatosis type 2 (NF2)-related vestibular schwannomas received bevacizumab. Eight of the 13 patients with initial hearing loss (61%) showed objective hearing improvement within six months of treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::29358d093473ae42ed110cca94211ac8
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=17463
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=17463
Autor:
Baroni LV, Rugilo C, Lubieniecki F, Sampor C, Freytes C, Nobre L, Hansford JR, Malalasekera VS, Zapotocky M, Dodgshun A, Martinez OC, Morales-La Madrid A, Lavarino C, Suñol M, Rutkowski S, Schuller U, Bouffet E, Ramaswamy V, Alderete D
Publikováno v:
PEDIATRIC BLOOD & CANCER
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Central nervous system high-grade neuroepithelial tumor with MN1 alteration (CNS HGNET-MN1) is a rare recently described entity. Fourteen CNS HGNET-MN1 patients were identified using genome-wide methylation arrays/RT-PCR across seven institutions. Al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::24a38faaa3b62e3a72deacea2ab660c1
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=18195
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=18195
Autor:
Achatz MI, Porter CC, Brugières L, Druker H, Frebourg T, Foulkes WD, Kratz CP, Kuiper RP, Hansford JR, Salvador-Hernandez H, Nathanson KL, Kohlmann WK, Doros L, Onel K, Schneider KW, Scollon SR, Tabori U, Tomlinson GE, Evans DGR, Plon SE
Publikováno v:
CLINICAL CANCER RESEARCH
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Hereditary gastrointestinal cancer predisposition syndromes have been well characterized, but management strategies and surveillance remain a major challenge, especially in childhood. In October 2016, the American Association for Cancer Research orga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6b87aa1608de80e4373a9a308601e197
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12672
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12672
Autor:
Weiss, William, Gottardo, NG, Hansford, JR, McGlade, JP, Alvaro, F, Ashley, DM, Bailey, S, Baker, DL, Bourdeaut, F, Cho, YJ, Clay, M
Publikováno v:
Weiss, William; Gottardo, NG; Hansford, JR; McGlade, JP; Alvaro, F; Ashley, DM; et al.(2014). Medulloblastoma Down under 2013: A report from the third annual meeting of the International Medulloblastoma Working Group. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/5q51j85x
Medulloblastoma is curable in approximately 70 % of patients. Over the past decade, progress in improving survival using conventional therapies has stalled, resulting in reduced quality of life due to treatment-related side effects, which are a major
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::7376b92254837829e5c140e0ac583603
http://www.escholarship.org/uc/item/5q51j85x
http://www.escholarship.org/uc/item/5q51j85x
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Antimicrobial Chemotherapy (JAC); Jul2012, Vol. 67 Issue 7, p1807-1809, 3p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kalish JM; Children's Hospital of Philadelphia, Philadelphia, PA, United States., Becktell KD; Medical College of Wisconsin, Milwaukee, WI, United States., Bougeard G; University of Rouen Normandy and Inserm U1245 and CHU Rouen, Rouen, France., Brodeur GM; Children's Hospital of Philadelphia, Philadelphia, PA, United States., Diller LR; Dana-Farber Cancer Institute, Boston, MA, United States., Doria AS; Hospital for Sick Children, Canada., Hansford JR; South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Klein SD; Children's Hospital of Philadelphia, United States., Kohlmann WK; University of Utah, Salt Lake City, UT, United States., Kratz CP; Hannover Medical School, Hannover, Germany., MacFarland SP; Children's Hospital of Philadelphia, Philadephia, PA, United States., Pajtler KW; German Cancer Research Center, Heidelberg, Germany., Rednam SP; Baylor College of Medicine, Houston, TX, United States., Schienda J; Dana-Farber Cancer Institute, Boston, MA, United States., States LJ; Children's Hospital of Philadelphia, Philadelphia, PA, United States., Villani A; Hospital for Sick Children, Toronto, Ontario, Canada., Weksberg R; Hospital for Sick Children, Toronto, State, Canada., Zelley K; Children's Hospital of Philadelphia, Philadelphia, PA, United States., Tomlinson GE; The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States., Brzezinski JJ; Hospital for Sick Children, Toronto, Canada.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 25. Date of Electronic Publication: 2024 Sep 25.
Autor:
Perrino MR; St. Jude Children's Research Hospital, Memphis, TN, United States., Das A; Hospital for Sick Children, Toronto, Canada., Scollon SR; Baylor College of Medicine, Houston, TX, United States., Mitchell SG; Emory University, Atlanta, GA, United States., Greer MC; Hospital for Sick Children, Toronto, Ontario, Canada., Yohe ME; National Cancer Institute, Frederick, MD, United States., Hansford JR; South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Kalish JM; Children's Hospital of Philadelphia, Philadelphia, PA, United States., Schultz KAP; Children's Minnesota, Minneapolis, MN, United States., MacFarland SP; Children's Hospital of Philadelphia, Philadephia, PA, United States., Kohlmann WK; University of Utah, Salt Lake City, UT, United States., Lupo PJ; Baylor College of Medicine, Houston, TX, United States., Maxwell KN; University of Pennsylvania, Philadelphia, PA, United States., Pfister SM; Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany., Weksberg R; Hospital for Sick Children, Toronto, State, Canada., Michaeli O; Schneider Children's Medical Center of Israel, Patach Tikva, Israel., Jongmans MCJ; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Tomlinson GE; The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States., Brzezinski J; Hospital for Sick Children, Toronto, Canada., Tabori U; Hospital for Sick Children, Toronto, Ontario, Canada., Ney GM; National Institutes of Health, Rockville, Maryland, United States., Gripp KW, Gross AM; National Cancer Institute, Bethesda, MD, United States., Widemann BC; National Cancer Institute, Bethesda, MD, United States., Stewart DR; National Cancer Institute, Bethesda, MD, United States., Woodward ER; Manchester University NHS Foundation Trust, Manchester, United Kingdom., Kratz CP; Hannover Medical School, Hannover, Germany.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Aug 28. Date of Electronic Publication: 2024 Aug 28.
Autor:
Das A; Division of Haematology Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada., MacFarland SP; Division of Oncology, Cancer Predisposition Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Meade J; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Hansford JR; Michael Rice Centre for Hematology and Oncology, Adelaide, South Australia, Australia.; South Australia Health and Medical Research Institute, Adelaide, South Australia, Australia.; South Australia ImmunoGENomics Cancer Institute, University of Adelaide, Adelaide, South Australia, Australia., Schneider KW; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Kuiper RP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Genetics, Utrecht University Medical Center, Utrecht, the Netherlands., Jongmans MCJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Genetics, Utrecht University Medical Center, Utrecht, the Netherlands., Lesmana H; Department of Pediatric Hematology/Oncology and BMT, Cleveland Clinic, Cleveland, Ohio., Schultz KAP; Cancer and Blood Disorders, Children's Minnesota, Minneapolis, Minnesota., Nichols KE; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Durno C; Division of Gastroenterology and Hepatology, The Hospital for Sick Children, Toronto, Ontario, Canada.; The Zane Cohen Center, Mount Sinai Hospital, Toronto, Ontario, Canada., Zelley K; Hereditary Cancer Predisposition Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Porter CC; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia., States LJ; Department of Radiology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania., Ben-Shachar S; Clalit Research Institute, Ramat-Gan, Tel Aviv University, Tel-Aviv, Israel., Savage SA; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland., Kalish JM; Division of Human Genetics and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Departments of Pediatrics and Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Walsh MF; Divisions of Solid Tumor and Clinical Genetics, Memorial Sloan Kettering Cancer Center, New York, New York., Scott HS; Center for Cancer Biology, SA Pathology and University of South Australia, Adelaide, South Australia, Australia., Plon SE; Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas., Tabori U; Division of Haematology Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Aug 15; Vol. 30 (16), pp. 3378-3387.